Skip to content

Depuy Cemented Hip Prosthesis

by Depuy, Inc. 510(k)

Active United States

510(k) K942370

Overview

The Depuy Cemented Hip Prosthesis is a Cemented Hip Prosthesis (FDA nomenclature JDI), designed for total hip arthroplasty. It provides a femoral component fixed to bone using bone cement, restoring joint function in patients with degenerative joint disease, fractures, or severe arthritis. The prosthesis includes a closed-design stem and a standard collar for enhanced stability during implantation.

This device is intended for use in orthopedic surgery settings by trained professionals. Supplied sterile and intended for single-use, it requires surgical implantation under aseptic conditions. The prosthesis is approved under FDA 510K clearance (K942370) and adheres to traditional orthopedic submission pathways. Storage must follow manufacturer guidelines to maintain sterility and structural integrity.

AI-generated from registry data, 19 Sep 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK942370 Date10 Nov 1994ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
JDI
Device Class
Class II
Regulation
21 CFR Part 888.3350
Advisory Committee
Orthopedic
FDA Decision
SESE Substantially Equivalent

Other devices from Depuy, Inc.

See all devices from Depuy, Inc. →

Questions

  • What types of patients is this hip prosthesis designed to help, and how does it work in their bodies?

    This prosthesis is specifically designed for patients suffering from degenerative joint disease, fractures, or severe arthritis that affect the hip joint. It works by replacing the damaged joint surfaces with a femoral component that is fixed to the bone using bone cement, restoring stability and function. The closed-design stem and standard collar enhance stability during implantation, allowing patients to regain mobility and reduce pain.

  • Is this device meant to be reused after a single surgical procedure, or is it intended for one-time use?

    The Depuy Cemented Hip Prosthesis is supplied sterile and intended for single-use only. Due to its sterile packaging and the nature of orthopedic implants, reuse is not recommended or approved, as it could compromise patient safety and sterility during surgery.

  • How should I store this device to ensure it remains effective and safe for use?

    Storage must follow the manufacturer’s guidelines to preserve sterility and structural integrity. Since it is sterile upon receipt, it should be kept in its original packaging until use, protected from contamination, moisture, and extreme temperatures. Avoid exposing it to direct sunlight or rough handling, as this could damage the components before surgery.

  • What distinguishes this prosthesis from others in terms of its design, and why might that matter during surgery?

    This prosthesis features a closed-design stem and a standard collar, which are designed to improve stability during implantation. The closed stem reduces the risk of loosening over time, while the collar provides additional support at the junction between the prosthesis and bone. These design elements help ensure a more secure fit, which can be particularly important for patients with complex bone structures or those requiring long-term durability.

  • How do I know this device meets regulatory standards, and what does the ‘FDA 510K’ clearance mean for its use?

    The device holds an FDA 510K clearance (K942370), meaning it was determined to be substantially equivalent to a legally marketed predicate device under the traditional orthopedic submission pathway. This clearance confirms that it meets FDA safety and effectiveness requirements for use in total hip arthroplasty when implanted by trained professionals in orthopedic surgery settings. The clearance does not imply it is intended for any specific condition beyond what is described in the device’s labeling.